A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer
Article in npj Precision Oncology (February 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in npj Precision Oncology (February 2024)
Article in Targeted Oncology (October 2022)
Preprint in bioRxiv (May 2022)